Most cancer-associated mutations in SF3B1 can lead to the usage of an alternative 3′ splice site located upstream of the canonical 3′ splice site (DeBoever et al., 2015) or the usage of an alternative branch point (Darman et al., 2015). This evidence concerns the gene SF3B1 and cancer.